Using a new drug to improve response to radiotherapy and hormone therapy
Grant information
Institution - Queen's University Belfast
Researcher - Professor Simon McDade and Dr Melissa LaBonte-Wilson
Grant Award - £374,306
Duration of Funding - 2022-2025
Status - Complete
Reference - RIA19-ST2-020
This grant is supported in the memory of John Paynter
Our findings show that blocking HDACs could make hormone therapy and radiotherapy work better. Using the unique models and datasets from this project, we are now working out whether HDAC inhibitors themselves, or drugs that target the processes they control, offer the best route to better, longer-lasting responses for men.
Why did we fund this project?
Radiotherapy used together with hormone therapy can be an effective treatment for men with locally advanced prostate cancer.
However, for some men, their cancer will sadly return.
That’s why we funded Prof Simon McDade and Dr Melissa LaBonte-Wilson to investigate whether a new drug could help make radiotherapy and hormone therapy more effective.
What did the researchers do?
The researchers tested whether a drug that blocks proteins called histone deacetylases (HDACs) could help kill prostate cancer cells when combined with hormone therapy and radiotherapy.
They then looked for clues that show doctors the treatment is working.
What did the researchers achieve?
They found that the drug reduced the activity of the androgen receptor, a known driver of prostate cancer growth. It also triggered a process called apoptosis, which causes cancer cells to die.
Importantly, they identified clues that could help doctors assess how well the drug is working.
How will this benefit men?
These findings suggest that drugs targeting HDACs could help hormone therapy and radiotherapy work more effectively.
The team will now test alternative drugs that also target HDACs to identify the most promising one to take forward to clinical trials.
If successful, this research could lead to a new treatment option for men with early-stage prostate cancer.
Help us fund more research like this
Your donation helps us fund lifesaving research into better ways to diagnose prostate cancer.